Public-registry site landscape for NCT06065059, a Breast Cancer study sponsored by Tango Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06065059 (registry record) |
| Sponsor | Tango Therapeutics, Inc. |
| Condition(s) | Breast Cancer; Ovarian Cancer; Pancreas Cancer; Prostate Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 7 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT06065059 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →